COVIRNA

Description
A diagnostic test to improve surveillance and care of COVID-19 patients
Accession number
07a1b414-d9b7-11eb-b117-d0577bab103e
Project acronym
covirna
Project website
Start date
2020-11-01
End date
2022-10-31
Types
Keywords
Accession number Title Create date Study hosted at UL
e6f84ce4-04f3-11ec-95a4-d0577bab103e LIH-PREDI-COVID 2020-11-01 LIH-PREDI-COVID Yes
e6f87414-04f3-11ec-b012-d0577bab103e UDUS-MiRCOVID 2020-11-01 UDUS-MiRCOVID Yes
e6f87416-04f3-11ec-b619-d0577bab103e PSD-COVID19-OMICS 2020-11-01 PSD-COVID19-OMICS Yes
e6f8741e-04f3-11ec-9af9-d0577bab103e HSCSP-COVIRNA 2020-11-01 HSCSP-COVIRNA Yes
Title Primary purpose Study type Organism
LIH-PREDI-COVID the samples to be used within COVIRNA were collected as part of the clinical study registered with the "ClinicalTrials.gov Identifier: NCT04332094". Randomized Interventional Pilot Phase II Clinical Trial; SARS-CoV-2 infection; Primary outcomes: mechanical ventilation, In-hospital mortality.
PREDI-COVID participants` samples and data for COVIRNA
Homo sapiens
UDUS-MiRCOVID The study aims to evaluate the involvement of microRNAs in severe COVID-19. Plasma and urine samples is collected at 5 different time points. MicroRNA levels are analyzed and compared in severely ill COVID patients with regard in acute kidney injury and heart failure.
MiRCOVID participants` samples and data for COVIRNA
Homo sapiens
PSD-COVID19-OMICS COVIRNA is part of COVID19_OMICS which is an observational, prospective study conducted by IRCCS Policlinico San Donato that provides the evaluation of circulating biomarkers predicting the clinical evolution in patients with COVID-19.
PSD COVID19 OMICS
Homo sapiens
ULEI-PROVID-PROGRESS-1 U07.1! , COVID-19, SARS-CoV-2 infection, prospective, longitudinal, observational, multi-center, medical history, clinical characteristics, laboratory parameters, quality of life, mechanical ventilation, medication, treatments
PROVID cohort of hospitalized COVID-19 patients
Homo sapiens
ULEI-PROVID-CAPNETZ-2 U07.1! , COVID-19, SARS-CoV-2 infection, prospective, longitudinal, observational, multi-center, medical history, clinical characteristics, laboratory parameters, quality of life, mechanical ventilation, medication, treatments
PROVID cohort of hospitalized COVID-19 patients
Homo sapiens
HSCSP-COVIRNA the samples to be used within COVIRNA were collected as part of the clinical study registered with the "ClinicalTrials.gov Identifier: NCT04332094". Randomized Interventional Pilot Phase II Clinical Trial; SARS-CoV-2 infection; Primary outcomes: mechanical ventilation, In-hospital mortality.
TOCOVID
Homo sapiens